tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Income Statement

Compare
1,583 Followers

Ocular Therapeutix Income Statement

Last quarter (Q4 2025), Ocular Therapeutix's total revenue was $13.25M, a decrease of -22.43% from the same quarter last year. In Q4, Ocular Therapeutix's net income was $-64.65M. See Ocular Therapeutix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 51.82M$ 63.72M$ 58.44M$ 51.49M$ 43.52M
Gross Profit
$ 45.25M$ 58.10M$ 53.16M$ 46.95M$ 39.12M
Operating Expenses
$ 315.39M$ 229.88M$ 135.54M$ 125.61M$ 117.15M
Depreciation and Amortization
$ 4.32M$ 3.79M$ 2.98M$ 2.11M$ 2.42M
EBITDA
$ -249.78M$ -176.14M$ -66.42M$ -61.91M$ 2.54M
Operating Income
$ -270.02M$ -171.78M$ -82.38M$ -78.65M$ -78.04M
Other Income/Expenses
$ 4.08M$ -21.73M$ 1.65M$ 7.62M$ 71.48M
Pretax Income
$ -265.94M$ -193.51M$ -80.74M$ -71.04M$ -6.55M
Net Income
$ -265.94M$ -193.51M$ -80.74M$ -71.04M$ -6.55M
Per Share Metrics
Basic EPS
$ -1.42$ -1.22$ -1.09$ -1.04$ -1.05
Diluted EPS
$ -1.42$ -1.22$ -1.02$ -0.97$ -0.98
Weighted Average Shares Outstanding
187.24M 158.26M 79.83M 76.88M 76.39M
Weighted Average Shares Outstanding (Diluted)
187.24M 158.26M 85.60M 82.64M 82.16M
Currency in USD

Ocular Therapeutix Earnings and Revenue History